197 related articles for article (PubMed ID: 20580684)
1. Parathyroid hormone and bisphosphonate have opposite effects on stress fracture repair.
Sloan AV; Martin JR; Li S; Li J
Bone; 2010 Aug; 47(2):235-40. PubMed ID: 20580684
[TBL] [Abstract][Full Text] [Related]
2. Effect of short-term treatment with alendronate on ulnar bone adaptation to cyclic fatigue loading in rats.
Barrett JG; Sample SJ; McCarthy J; Kalscheur VL; Muir P; Prokuski L
J Orthop Res; 2007 Aug; 25(8):1070-7. PubMed ID: 17444501
[TBL] [Abstract][Full Text] [Related]
3. Increases in callus formation and mechanical strength of healing fractures in old rats treated with parathyroid hormone.
Andreassen TT; Fledelius C; Ejersted C; Oxlund H
Acta Orthop Scand; 2001 Jun; 72(3):304-7. PubMed ID: 11480610
[TBL] [Abstract][Full Text] [Related]
4. Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling.
McDonald MM; Dulai S; Godfrey C; Amanat N; Sztynda T; Little DG
Bone; 2008 Oct; 43(4):653-62. PubMed ID: 18582604
[TBL] [Abstract][Full Text] [Related]
5. Human parathyroid hormone (1-34) accelerates the fracture healing process of woven to lamellar bone replacement and new cortical shell formation in rat femora.
Komatsubara S; Mori S; Mashiba T; Nonaka K; Seki A; Akiyama T; Miyamoto K; Cao Y; Manabe T; Norimatsu H
Bone; 2005 Apr; 36(4):678-87. PubMed ID: 15781006
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological treatment of osteopenia induced by gastrectomy or ovariectomy in young female rats.
Andersson N; Surve VV; Lehto-Axtelius D; Andersson K; Ryberg B; Ohlsson C; Håkanson R
Acta Orthop Scand; 2004 Apr; 75(2):201-9. PubMed ID: 15180236
[TBL] [Abstract][Full Text] [Related]
7. A single systemic dose of pamidronate improves bone mineral content and accelerates restoration of strength in a rat model of fracture repair.
Amanat N; Brown R; Bilston LE; Little DG
J Orthop Res; 2005 Sep; 23(5):1029-34. PubMed ID: 16140188
[TBL] [Abstract][Full Text] [Related]
8. The anabolic action of intermittent PTH in combination with cathepsin K inhibitor or alendronate differs depending on the remodeling status in bone in ovariectomized mice.
Yamane H; Sakai A; Mori T; Tanaka S; Moridera K; Nakamura T
Bone; 2009 Jun; 44(6):1055-62. PubMed ID: 19303837
[TBL] [Abstract][Full Text] [Related]
9. Combined effects of recombinant human BMP-7 (rhBMP-7) and parathyroid hormone (1-34) in metaphyseal bone healing.
Morgan EF; Mason ZD; Bishop G; Davis AD; Wigner NA; Gerstenfeld LC; Einhorn TA
Bone; 2008 Dec; 43(6):1031-8. PubMed ID: 18761113
[TBL] [Abstract][Full Text] [Related]
10. Additive effects of PTH and bisphosphonates on the bone healing response to metaphyseal implants in rats.
Aspenberg P; Wermelin K; Tengwall P; Fahlgren A
Acta Orthop; 2008 Feb; 79(1):111-5. PubMed ID: 18283582
[TBL] [Abstract][Full Text] [Related]
11. Low-intensity pulsed ultrasound and nonsteroidal anti-inflammatory drugs have opposing effects during stress fracture repair.
Li J; Waugh LJ; Hui SL; Burr DB; Warden SJ
J Orthop Res; 2007 Dec; 25(12):1559-67. PubMed ID: 17593538
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonate treatment delays stress fracture remodeling in the rat ulna.
Kidd LJ; Cowling NR; Wu AC; Kelly WL; Forwood MR
J Orthop Res; 2011 Dec; 29(12):1827-33. PubMed ID: 21598308
[TBL] [Abstract][Full Text] [Related]
13. Maintenance of increased bone mass after recombinant human parathyroid hormone (1-84) with sequential zoledronate treatment in ovariectomized rats.
Rhee Y; Won YY; Baek MH; Lim SK
J Bone Miner Res; 2004 Jun; 19(6):931-7. PubMed ID: 15125792
[TBL] [Abstract][Full Text] [Related]
14. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
Shen V; Birchman R; Wu DD; Lindsay R
J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
[TBL] [Abstract][Full Text] [Related]
15. Effect of intermittent administration of human parathyroid hormone on bone mineral density and arthritis in rats with collagen-induced arthritis.
Fukata S; Hagino H; Okano T; Yamane I; Kameyama Y; Teshima R
Arthritis Rheum; 2004 Dec; 50(12):4060-9. PubMed ID: 15593226
[TBL] [Abstract][Full Text] [Related]
16. Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits.
Hirano T; Burr DB; Turner CH; Sato M; Cain RL; Hock JM
J Bone Miner Res; 1999 Apr; 14(4):536-45. PubMed ID: 10234574
[TBL] [Abstract][Full Text] [Related]
17. The effect of PTH(1-34) on fracture healing during different loading conditions.
Ellegaard M; Kringelbach T; Syberg S; Petersen S; Beck Jensen JE; Brüel A; Jørgensen NR; Schwarz P
J Bone Miner Res; 2013 Oct; 28(10):2145-55. PubMed ID: 23585311
[TBL] [Abstract][Full Text] [Related]
18. Density and structural changes in the bone of growing rats after weekly alendronate administration with and without a methotrexate challenge.
Spadaro JA; Damron TA; Horton JA; Margulies BS; Murray GM; Clemente DA; Strauss JA
J Orthop Res; 2006 May; 24(5):936-44. PubMed ID: 16609966
[TBL] [Abstract][Full Text] [Related]
19. Osteoprotegerin treatment impairs remodeling and apparent material properties of callus tissue without influencing structural fracture strength.
Ulrich-Vinther M; Andreassen TT
Calcif Tissue Int; 2005 Apr; 76(4):280-6. PubMed ID: 15812581
[TBL] [Abstract][Full Text] [Related]
20. Individual and combined effects of exercise and alendronate on bone mass and strength in ovariectomized rats.
Fuchs RK; Shea M; Durski SL; Winters-Stone KM; Widrick J; Snow CM
Bone; 2007 Aug; 41(2):290-6. PubMed ID: 17544352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
